{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:48:53Z","timestamp":1761882533168,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI19\/01661"],"award-info":[{"award-number":["FIS PI19\/01661"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Otorrinolaringologica (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.otoeng.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:06:14Z","timestamp":1665551174000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is long-term screening for lung cancer justified in patients with head and neck carcinoma?"],"prefix":"10.1016","volume":"74","author":[{"given":"Xavier","family":"Le\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"de Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel","family":"Quer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otoeng.2022.10.002_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7","article-title":"Second neoplasm in patients with head and neck cancer","volume":"21","author":"Le\u00f3n","year":"1999","journal-title":"Head Neck"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0010","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/lary.24719","article-title":"Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years","volume":"124","author":"Tiwana","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0015","first-page":"823","article-title":"The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial","volume":"10","author":"Khuri","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.otorri.2018.11.003","article-title":"Riesgo de aparici\u00f3n de segundas neopl\u00e0sies y neoplasias sucesivas en pacientes con un tumor \u00edndice de cabeza y cuello","volume":"71","author":"Le\u00f3n","year":"2020","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ctrv.2009.08.007","article-title":"Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up","volume":"35","author":"Manikantan","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0001-6519(02)78299-X","article-title":"Dise\u00f1o, mantenimiento y explotaci\u00f3n de una base de datos oncol\u00f3gica para pacientes con tumores malignos de cabeza y cuello","volume":"53","author":"Le\u00f3n","year":"2002","journal-title":"Acta Otorrinolaringol Esp"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0035","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hed.22006","article-title":"Second primary lung cancer after head and neck squamous cell cancer: population-based study of risk factors","volume":"34","author":"Milano","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/lary.27422","article-title":"Second primary lung malignancy following head and neck squamous cell carcinoma","volume":"129","author":"Crippen","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/0003489415582259","article-title":"Second primary lung cancer after head and neck cancer: implications for screening computed tomography","volume":"124","author":"Pagedar","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0050","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.23798","article-title":"Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries","volume":"123","author":"Chuang","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40463-015-0057-7","article-title":"A survey on pulmonary screening practices among otolaryngology-head & neck surgeons across Canada in the post treatment surveillance of head and neck squamous cell carcinoma","volume":"44","author":"Madana","year":"2015","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00192255","article-title":"Yearly chest radiography in the early detection of lung cancer following laryngeal c\u00e0ncer","volume":"249","author":"Engelen","year":"1992","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0065","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/00005537-200012000-00010","article-title":"Lung cancer after head and neck cancer: role of chest radiography","volume":"110","author":"Shah","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2310\/7070.2003.37133","article-title":"Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer","volume":"32","author":"Warner","year":"2003","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00405-006-0094-y","article-title":"CT staging and surveillance of the thorax in patients with newly diagnosed and recurrent squamous cell carcinoma of the head and neck: is it necessary?","volume":"263","author":"Glynn","year":"2006","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archotol.134.10.1050","article-title":"Role of chest computed tomography in head and neck cancer","volume":"134","author":"Hsu","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0090","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0095","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S1470-2045(14)70387-0","article-title":"Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers","volume":"15","author":"Horeweg","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20400","article-title":"The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer","volume":"20","author":"Field","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/crj.12222","article-title":"A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population?","volume":"10","author":"Fu","year":"2016","journal-title":"Clin Respir J"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0110","first-page":"272","article-title":"Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis","volume":"7","author":"Pyenson","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamaoncol.2015.2472","article-title":"Cost-effectiveness of lung cancer screening in Canada","volume":"1","author":"Goffin","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-017-0924-3","article-title":"Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting","volume":"15","author":"Treskova","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lungcan.2018.05.008","article-title":"Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking\u2014a modelling study","volume":"121","author":"Tomonaga","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2017.04.001","article-title":"Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan","volume":"108","author":"Yang","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oraloncology.2016.11.011","article-title":"The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma","volume":"64","author":"Martel","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.otoeng.2022.10.002_bib0140","first-page":"645","article-title":"Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study","volume":"20","author":"Le\u00f3n","year":"2009","journal-title":"Cancer Causes Control"}],"container-title":["Acta Otorrinolaringologica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573522000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173573522000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:47:28Z","timestamp":1761878848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173573522000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2173573522000941"],"URL":"https:\/\/doi.org\/10.1016\/j.otoeng.2022.10.002","relation":{},"ISSN":["2173-5735"],"issn-type":[{"type":"print","value":"2173-5735"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is long-term screening for lung cancer justified in patients with head and neck carcinoma?","name":"articletitle","label":"Article Title"},{"value":"Acta Otorrinolaringologica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otoeng.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.otorri.2022.05.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Otorrinolaringolog\u00eda y Cirug\u00eda de Cabeza y Cuello.","name":"copyright","label":"Copyright"}]}}